Contact Us Created with Snap ENGINEERING ANTIBODY AND CYTOKINE THERAPEUTICS FROM THE GROUND UP .\37 bcc4295-a48f-4773-8771-538c9ad3e5b4 { fill: #27596a; } .e776b149-a672-4127-a758-4d9a0bcaff30 { fill: none; stroke: #27596a; stroke-miterlimit: 10; stroke-width: 2.9px; } icon_plugPlay_blue Created with Snap .st0{fill:#A6A8AB;} .st1{fill:#9578B5;} .st2{opacity:0.85;fill:url(#SVGID_1_);} .st3{opacity:0.85;fill:url(#SVGID_2_);} .st4{fill:#DCE68E;} .st5{fill:#D0D2D3;} .st6{opacity:0.85;fill:url(#SVGID_3_);} .st7{opacity:0.85;fill:url(#SVGID_4_);} .st8{opacity:0.85;fill:url(#SVGID_5_);} .st9{opacity:0.85;fill:url(#SVGID_6_);} .st10{fill:#F8B978;} .st11{opacity:0.85;fill:url(#SVGID_7_);} .st12{opacity:0.85;fill:url(#SVGID_8_);} .st13{opacity:0.85;fill:url(#SVGID_9_);} .st14{opacity:0.85;fill:url(#SVGID_10_);} .st15{fill:none;stroke:#FFFFFF;stroke-width:2.9023;stroke-miterlimit:10;} .st16{fill:#FFFFFF;} .st17{opacity:0.85;fill:#FFFFFF;} Created with Snap Plug-and-Play Technology XmAb Fc domains can be substituted into nearly any antibody, creating the basis for numerous partnerships. .st0{fill:#A6A8AB;} .st1{fill:#9578B5;} .st2{opacity:0.85;fill:url(#SVGID_1_);} .st3{opacity:0.85;fill:url(#SVGID_2_);} .st4{fill:#DCE68E;} .st5{fill:#D0D2D3;} .st6{opacity:0.85;fill:url(#SVGID_3_);} .st7{opacity:0.85;fill:url(#SVGID_4_);} .st8{opacity:0.85;fill:url(#SVGID_5_);} .st9{opacity:0.85;fill:url(#SVGID_6_);} .st10{fill:#F8B978;} .st11{opacity:0.85;fill:url(#SVGID_7_);} .st12{opacity:0.85;fill:url(#SVGID_8_);} .st13{opacity:0.85;fill:url(#SVGID_9_);} .st14{opacity:0.85;fill:url(#SVGID_10_);} .st15{fill:none;stroke:#FFFFFF;stroke-width:2.9023;stroke-miterlimit:10;} .st16{fill:#FFFFFF;} .st17{opacity:0.85;fill:#FFFFFF;} Created with Snap Diversified Antibody and Cytokine Drug Pipeline Our unique portfolio of XmAb-engineered Fc domains enable highly selective immune-modulators and targeted cancer therapies. .st0{fill:#A6A8AB;} .st1{fill:#9578B5;} .st2{opacity:0.85;fill:url(#SVGID_1_);} .st3{opacity:0.85;fill:url(#SVGID_2_);} .st4{fill:#DCE68E;} .st5{fill:#D0D2D3;} .st6{opacity:0.85;fill:url(#SVGID_3_);} .st7{opacity:0.85;fill:url(#SVGID_4_);} .st8{opacity:0.85;fill:url(#SVGID_5_);} .st9{opacity:0.85;fill:url(#SVGID_6_);} .st10{fill:#F8B978;} .st11{opacity:0.85;fill:url(#SVGID_7_);} .st12{opacity:0.85;fill:url(#SVGID_8_);} .st13{opacity:0.85;fill:url(#SVGID_9_);} .st14{opacity:0.85;fill:url(#SVGID_10_);} .st15{fill:none;stroke:#FFFFFF;stroke-width:2.9023;stroke-miterlimit:10;} .st16{fill:#FFFFFF;} .st17{opacity:0.85;fill:#FFFFFF;} Created with Snap Unleashing Bispecific Antibodies Our technology can simultaneously address multiple disease targets while improving half-life, stability and ease of manufacturing. CONTACT US info@xencor.com collaborate@xencor.com Xencor, Inc. Headquarters 111 West Lemon Avenue Monrovia, CA 91016 (626) 305-5900 Xencor, Inc. San Diego 12481 High Bluff Dr., Suite 200 San Diego, CA 92130 (858) 617-6155 © 2021 Xencor. All Rights Reserved. | Privacy Policy